Lipophilic 5-fluorouracil prodrug encapsulated xylan-stearic acid conjugates nanoparticles for colon cancer therapy
Introduction
Cancer is one of the serious and major health problem in the world [1,2]. Among the various cancers, colon cancer is highly prevalent and third most leading causes of death in both men and women [3]. 5-FU is one of the most prescribed chemotherapeutic agent used in colon cancer therapy, however its short half-life, poor bioavaibility, adverse sides effects and low encapsulation efficacy, limits its clinic applications [[4], [5], [6], [7]]. In order to extend the half-life or prolong circulation time in-vivo, enhance accumulation in tumor sites through enhanced permeability and retention (EPR) effect and improve the loading efficacy, various nano sized drug delivery systems including liposomes, micelles, lipid based nanoparticles and polymeric nanoparticles have been developed in recent years [8]. Usually, 5-FU shows lower encapsulation efficacy in hydrophobic core of polymeric nanoparticles due to its hydrophilic nature [9,10]. The encapsulation of 5-FU in hydrophobic core of polymeric materials could be made feasible through lipid-drug conjugate (lipophilic prodrug) approach [4]. Numerous lipids such as docosahexaenoic acid, squalenoic acid, palmitic acid and stearic acid have been explored widely in drug delivery applications because of their excellent biocompatibility and low cytotoxicity [[11], [12], [13]].
In recent years, self-assembled nanoparticles based on grafting of hydrophobic moieties to the hydrophilic back bone of polymers have received considerable interest as a potential carrier in drug delivery due to their unique core-shell architecture [1,[14], [15], [16], [17]]. The hydrophobic core of nanoparticles can be utilized as a cargo space for poorly water-soluble drugs, while the hydrophilic outer shell allows a long circulation of drug by preventing the interactions between the core and the blood components [18]. A wide range of polymers synthetic as well as natural have been used in the development of self-assembled nanoparticles [[19], [20], [21], [22], [23], [24]].
In particular, xylan is a plant cell extracted natural biopolymer and recently used in various biological applications because of its excellent physiological and biological properties [25,26]. However, due to the hydrophilic nature of xylan, it cannot form self-assembled nanoparticles in aqueous system [27]. Therefore, to get the self-assembled nanoparticles, xylan was grafted with hydrophobic moiety such as stearic acid, which could form self-assembled nanoparticles in aqueous medium [28]. In this study, lipophilic 5-FU-stearic acid (5-FUSA) prodrug was synthesized to enhance the loading efficacy of 5-FU. Towards this aim first, xylan-stearic acid conjugates nanoparticles (Xyl-SA NPs) were prepared and then lipophilic 5-FUSA prodrug was encapsulated into the hydrophobic core Xyl-SA NPs through dialysis membrane method (Scheme 1). The inner core of Xyl-SA/5-FUSA NPs formed by hydrophobic moieties (stearic acid) encapsulates the lipophilic 5-FUAC prodrug through hydrophobic interaction and outer shell formed by hydrophilic moieties (Xylan) protects the loaded drug from non-specific uptake by reticuloendothelial system (RES), resulting in an improved circulation half-life of free drug (5-FU) and minimizing its side effects on healthy cells. Moreover, due to their nano size, they can penetrate deep in the tumor tissues through fine capillaries and take up efficiently by the cancer cells thus enhanced the therapeutic efficacy of drug (5-FU) [29,30] . The obtained Xyl-SA/5-FUSA NPs were characterized and further blood compatibility and in-vitro antitumor activity of Xyl-SA/5-FUSA NPs were also investigated for their potential application in cancer therapy.
Section snippets
Materials
5-fluorouracil (≥99%), formaldehyde solution (37 wt%), dialysis membrane (MWCO 12 kDa) and 3-(4, 5-dimethylthiazol-2-yl)-2, 5-diphenyl tetrazolium bromide (MTT) were received from Sigma-Aldrich (Bangalore, India). Stearic acid, 4-dimethylaminopyridine (DMAP) and N, N′-dicyclohexylcarbodiimide (DCC) were obtained from Himedia (Mumbai, India). The Human colorectal cancer cells (HT-29 and HCT-15) were obtained from NCCS Pune (India). All other reagents and solvents were of analytical grade and
Synthesis and characterization of Xyl-SA conjugates and lipophilic 5-FUSA prodrug
The synthesis of Xyl-SA conjugates was confirmed by FT-IR and 1H NMR spectroscopy. The FT-IR spectra of stearic acid exhibited the characteristics absorption bonds at 2920 cm−1, 2850 cm−1 and 1700 cm−1 corresponding to the stretching frequencies of the CH3, CH2 and CO groups (Fig. 2a). In the xylan spectrum, the peak at 3420 cm−1 is attributed to the stretching of OH group and the sharp band at 1632 cm−1due to absorbed water, while the peaks between 1465 and 1043 cm−1 arise from the stretching
Conclusion
The lipophilic prodrug encapsulated nano drug delivery system is a special kind of drug delivery system, which improves the loading efficacy of hydrophilic drug within the hydrophobic core of polymeric nanoperticulate. In this study, self-assembled nanoparticles based on amphiphilic xylan-stearic acid (Xyl-SA) conjugates have been developed successfully for the efficient delivery of 5-FU in cancer therapy. The loading efficacy of the hydrophilic drug (5-FU) into the hydrophobic core of Xyl-SA
Conflicts of interest
The authors declare they have no conflicts of interest.
Acknowledgments
The authors would like to thanks the MHRD New Delhi for a Ph.D. scholarship. The authors also thanks department of chemistry (IIT-Roorkee) for their convenience helps.
References (45)
- et al.
5-fluorouracil-lipid conjugate: potential candidate for drug delivery through encapsulation in hydrophobic polyester-based nanoparticles
Acta Biomater.
(2014) - et al.
New utilization of Polygonum multiflorum polysaccharide as macromolecular carrier of 5-fluorouracil for controlled release and immunoprotection
Int. J. Biol. Macromol.
(2018) - et al.
Incorporation of novel 1-alkylcarbonyloxymethyl prodrugs of 5-fluorouracil into poly(lactide-co-glycolide) nanoparticles
Int. J. Pharm.
(2008) - et al.
Beta casein-micelle as a nano vehicle for solubility enhancement of curcumin; food industry application
LWT- Food Sci. Technol.
(2011) - et al.
Pullulan and pullulan derivatives as promising biomolecules for drug and gene targeting
Carbohydr. Polym.
(2015) - et al.
PH-sensitive chitosan-derived nanoparticles as doxorubicin carriers for effective anti-tumor activity: preparation and in vitro evaluation
Colloids Surf. B Biointerfaces
(2012) - et al.
Xyloglucan: a functional biomacromolecule for drug delivery applications
Int. J. Biol. Macromol.
(2017) - et al.
Development of a photoresponsive chitosan conjugated prodrug nano-carrier for controlled delivery of antitumor drug 5-fluorouracil
Int. J. Biol. Macromol.
(2019) - et al.
Polysaccharides and lignin based hydrogels with potential pharmaceutical use as a drug delivery system produced by a reactive extrusion process
Int. J. Biol. Macromol.
(2017) - et al.
Xylan derivatives and their application potential - mini-review of own results
Carbohydr. Polym.
(2014)
Galactosylated pullulan-curcumin conjugate micelles for site specific anticancer activity to hepatocarcinoma cells
Colloids Surf. B Biointerfaces
Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin
Int. J. Pharm.
Pullulan acetate nanoparticles prepared by solvent diffusion method for epirubicin chemotherapy
Colloids Surf. B Biointerfaces
Self-assembling materials for therapeutic delivery
Acta Biomater.
Polymeric nanoparticles: a study on the preparation variables and characterization methods
Mater. Sci. Eng. C
Construction of serum resistant micelles based on heparosan for targeted cancer therapy
Carbohydr. Polym.
Folate-modified carboxymethyl-chitosan/polyethylenimine/bovine serum albumin based complexes for tumor site-specific drug delivery
Carbohydr. Polym.
Hemocompatible curcumin-dextran micelles as pH sensitive pro-drugs for enhanced therapeutic efficacy in cancer cells
Carbohydr. Polym.
Precise ratiometric loading of PTX and DOX based on redox-sensitive mixed micelles for cancer therapy
Colloids Surf. B Biointerfaces
Synthesis of alginate derivative via the Ugi reaction and its characterization
Carbohydr. Polym.
Self-assembled nanoparticles based on galactosylated O-carboxymethyl chitosan-graft-stearic acid conjugates for delivery of doxorubicin
Int. J. Pharm.
Boronate-dextran: an acid-responsive biodegradable polymer for drug delivery
Biomaterials
Cited by (41)
Synthesize of pluronic-based nanovesicular formulation loaded with Pistacia atlantica extract for improved antimicrobial efficiency
2023, Arabian Journal of ChemistryNatural polysaccharides: Chemical properties and application in pharmaceutical formulations
2023, European Polymer JournalDesigning robust xylan/chitosan composite shells around drug-loaded MSNs: Stability in upper GIT and degradation in the colon microbiota
2023, Journal of Drug Delivery Science and TechnologySustained and targeted delivery of hydrophilic drug compounds: A review of existing and novel technologies from bench to bedside
2022, Journal of Drug Delivery Science and TechnologyCitation Excerpt :The stability of the particles upon heat sterilisation, however, was not investigated. Covalently bonded conjugates with the hydrophilic drugs, isoniazid and 5-fluorouracil, were detailed in recent publications by Pandit et al. [203] and Sauraj et al. [204], respectively. Isoniazid, an antitubercular drug, was covalently conjugated to stearic acid via nucleophilic acyl substitution of stearyl chloride to form a N-stearyl amide of isoniazid [203].
Biosynthesis of folic acid appended PHBV modified copper oxide nanorods for pH sensitive drug release in targeted breast cancer therapy
2022, International Journal of PharmaceuticsPreparation, physicochemical and pharmacological study of 10-hydroxycamptothecin solid dispersion with complexation agent – xylan-nonanoic acid amphiphilic conjugates
2022, International Journal of Biological MacromoleculesCitation Excerpt :Fatty acids have low toxicity and biocompatibility, which can increase the drug loading capacity of drug delivery system [26], and are suitable for the synthesis of amphiphilic compounds as lipophilic terminal. Some nanoparticles can be synthesized by grafting of fatty acids onto polysaccharides with excellent physical and biological properties such as chitosan [27], hyaluronic acid [28,29], dextran [30] and xylan [25] etc. to obtain amphiphilic polymers that can self-assemble to micelles when dissolved in water. The introduction of fatty acids as hydrophobic fragments into hydrophilic drugs to enhance their lipophilicity and thus their compatibility with lipophilic cell membranes will improve the bioavailability of drugs [31,32].